Biotechnology Analyst Lugo discusses three upcoming FDA decisions for gene therapies including Sarepta’s May 12 FDA Advisory Committee Meeting and May 29 PDUFA for SRP-9001, Krystal’s May 19 PDUFA for Vyjuvek (B-VEC) and BioMarin’s June 30 PDUFA for Roctavian on an Analyst/Industry conference call to be held on April 21 at 10 am. Webcast Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BMRN:
